Halozyme Therapeutics, Inc. (HALO) Thursday revealed the appointment of Darren Snellgrove as Chief Financial Officer, effective June 8, 2026.
Most recently, Snellgrove was with Johnson & Johnson leading investor relations. He brings more than 30 years experience.
Snellgrove will be responsible for leading Halozyme's financial operations and strategy, including capital allocation, corporate development and investor relations.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.